Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (2)
  • 2023 (8)
  • 2022 (6)
  • 2021 (6)
  • 2020 (4)
  • 2019 (2)

Subject

  • Drug Trafficking (371)
  • Synthetic drugs (179)
  • Guns/Weapons (83)
  • Overdose (58)
  • Prescription Drugs (58)
  • Arrests/Convictions - Major (39)
  • Gangs (34)
  • Diversion Division (33)
  • Take Back Day (33)
  • Major Law Enforcement Operation (29)
  • Fake Pills (27)
  • Outreach/Drug Prevention (26)
  • Public and Media Affairs - also see Congressional Affairs (20)
  • Fentanyl Awareness (16)
  • Money Laundering (15)
  • Task Forces/Task Force Officers (15)
  • OCDETF/Task Force (14)
  • Press Conferences (13)
  • Seizures (Drugs/Property) (13)
  • Congressional Affairs (12)
  • Guilty Plea (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • Extraditions (9)
  • One Pill Can Kill (9)
  • Red Ribbon (9)
  • Terrorism (8)
  • International/Foreign Operations (6)
  • Narcoterrorism (5)
  • Counterfeit Pills (4)
  • Dark Web- Internet Trafficking (4)
  • Fentanyl Free America (4)
  • Intergovernmental Affairs (4)
  • Critical Incident (3)
  • Campaigns (2)
  • HIDTA (2)
  • Scam Calls (2)
  • El Paso Intelligence Center (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Pharmaceuticals/Pharmacists/Physicians (30)

Drug Name

  • Oxycodone (10)
  • Fentanyl (2)
  • Cocaine (1)
  • GHB (1)
  • Ketamine (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (10)
  • Seattle (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • New York (21)
  • Sede (9)
Clear All Results
30 Results - Showing 1 to 10
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
PRESS RELEASE

Fort Salonga Urologist and Wife Charged with Criminal Sale of a Prescription for a Controlled Substance and Falsifying Business Records

SUFFOLK COUNTY, N.Y. – Suffolk County District Attorney Raymond A. Tierney and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III today announced the indictment of Francis and Jessica Martinis, of Fort Salonga, accused of Criminal Sale of Prescription for a Controlled Substance by a Practitioner and Falsifying...
PRESS RELEASE

Queens Pharmacist Sentenced to 60 Months in Prison for Illegally Distributing Oxycodone and Filing False Tax Returns

BROOKLYN, N.Y. - Today, Daniel E. Russo was sentenced to 60 months in prison by United States District Judge Dora L. Irizarry for conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. In...
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

Nurse Practitioner Arrested, Charged with Selling Oxymorphone

BUFFALO, N.Y. - U.S. Attorney Trini E. Ross announced today that Michael Ostolski, 55, of North Tonawanda, NY, was arrested and charged by criminal complaint with conspiracy to distribute oxymorphone. The charge carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Michael J...
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster